Preclinical prevent cancer program: preclinical efficacy and intermediate endpoint biomarkers.period of performance: 09/22/2015 - 09/21/2018

Ended Awarded Sep 22, 2015 Last action Jun 19, 2018

Contract number: HHSN261201500041I
Awardee: Sri International UEI SRG2J1WS9X63
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Task orders: 3 $1,225,427 obligated

Award facts

Opportunity: N01CN5500347 Solicitation number

Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Sep 25, 2015

Preclinical PREVENT Cancer Program for Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Jan 5, 2015
Combined order value: $1,225,427 Current and potential, with all options
Last date to order 100% complete: Sep 21, 2018
IDV ceiling 4% used: $29,800,000.00
Award type: Multiple award
Who can order: Only the awarding agency
NAICS code: 541711 Research and Development in Biotechnology
PSC: AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside: No set-aside
Competition: Full and Open Competition · 9 offers Negotiated Proposal / Quote
Pricing: Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task order	Ordering agency	Obligated	Awarded
R & D- medical: biomedical (basic research) award of task order "optimization and further development of mesothelin… HHSN26100003	National Cancer Institute (NIH)	$712,240	Sep 1, 2016
2015-E03B/ovarian cancer chemoprevention (SHETA2) period of performance 09/24/2015 - 09/23/2017 HHSN26100002	National Cancer Institute (NIH)	$509,357	Sep 24, 2015
Contract orientation and kick-off meeting PP: 9/22/2015 to 12/31/2015 HHSN26100001	National Cancer Institute (NIH)	$3,830	Sep 22, 2015

Action	Obligated	Date
Additional Work (new agreement, FAR part 6 applies) 2 · Preclinical prevent efficacy: IDIQ programmatic maximum increase	$0	Jun 19, 2018
Other Administrative Action 1	$0	May 12, 2016
Original award	$0	Sep 22, 2015

HHSN261201500041I was awarded to Sri International by National Cancer Institute (National Institutes of Health) on September 22, 2015.

Orders under HHSN261201500041I have obligated $1,225,427. HHSN261201500041I's own ceiling is $29,800,000.

3 orders have been placed under HHSN261201500041I, the latest on September 1, 2016.

HHSN261201500041I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Yes. HHSN261201500041I is part of PREVENT Cancer Program (PREVENT).

The extent of competition for HHSN261201500041I was full and open competition. The government received 9 offers.

On GovTribe

Try for free Login